Ist covid 19 eine gefaesserkrankung
Covid19-Sources
An atlas of continuous adaptive evolution in endemic human viruses
Americans Don’t Get to Have the Best New COVID Drug
Dr. Gustavo Aguirre-Chang on Twitter
Bacterial coinfections contribute to severe COVID-19 in winter
Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions
Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions
Could SARS-CoV-2 Have Bacteriophage Behavior or Induce the Activity of Other Bacteriophages?
Viral kinetics of sequential SARS-CoV-2 infections
In individuals with multiple infections, second infections were cleared more quickly than first infections. Furthermore, one’s relative speed of clearing infection roughly persisted across infections. Those with a relatively fast clearance speed in their first infection tended to have a relatively fast clearance speed in their second infection, and vice versa. Thus, while prior infection and vaccination can modulate a person’s viral kinetics in absolute terms, there may also exist some further immunological mechanism, conserved across sequential infections, that determines one’s strength of immune response against SARS-CoV-2 relative to others in the population.
A consistent finding between this and other studies on SARS-CoV-2 viral kinetics is that prior antigenic exposure, through infection or vaccination, tends to speed up viral clearance, and thus to reduce the duration of test positivity5,11,15. The duration of viral positivity has various consequences both for clinical management and for public health surveillance. For clinical management, test results should be interpreted in the context of a patient’s immune history, which can modulate both the extent and expected duration of viral shedding5,16. It may also be possible to adjust the recommended duration of post-infection isolation based on infection history.
COVID-19 vaccine-associated mortality in the Southern Hemisphere
SARS-CoV-2 infection induces DNA damage, through CHK1 degradation and impaired 53BP1 recruitment, and cellular senescence
Neurologic Effects of SARS-CoV-2 Transmitted among Dogs
Emmanuel on Twitter
Vipin M. Vashishtha on Twitter
Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study
Langzeitorganschäden bei einigen posthospitalisierten COVID-Patienten bestätigt
OrthopaeDenker on Twitter
SARS-CoV2 mRNA-vaccination-induced immunological memory in human non-lymphoid and lymphoid tissues
Helferzellen gegen Sars-CoV-2: Corona-Impfung: Körper baut Immungedächtnis in Organen auf
Klinische Daten: Immunreaktionen nach Booster mit Comirnaty XBB.1.5
Covid-19: Infections climb globally as EG.5 variant gains ground
Alteration of the blood-brain barrier by COVID-19 and its implication in the permeation of drugs into the brain
Column: Did Sweden beat the pandemic by refusing to lock down? No, its record is disastrous
First on CNN: HHS awards more than $500 million to study Covid-19 vaccine nasal sprays and more | CNN
Effective contact tracing can halve mass testing frequency needed to control respiratory virus pandemics
Influence of Prior SARS-CoV-2 Infection on COVID-19 Severity: Evidence from the National COVID Cohort Collaborative
Overall, prior infection was associated with a significant slightly elevated risk of severe disease.
Erratum for the Research Article “The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2” by J. E. Pekar et al.
Vaccine Effectiveness Against Long COVID in Children: A Report from the RECOVER EHR Cohort
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Postacute Risk of Non–Coronavirus Disease 2019 Infectious Disease Hospitalizations: A Nationwide Cohort Study of Danish Adults Aged ≥50 Years
T Cell Cross-reactivity in Autoimmune-like Hepatitis Triggered by COVID-19